Therapeutic response to H1-antihistamines and angioedema.
| Variable | Therapeutic response to H1-antihistamines | p-level | ||
|---|---|---|---|---|
| n | Presentn (%) | Not presentn (%) | ||
| Angioedema | ||||
| Present | 161 | 116 (71.17) | 45 (67.16) | χ2 = 0.36, p = 0.55 |
| Not present | 69 | 47 (28.83) | 22 (32.84) | |
Adapted from the author’s original, unpublished thesis data.
VT: Conceptualization, Investigation, Writing—original draft, Writing—review & editing, Formal analysis, Visualization. NTM: Validation, Writing—review & editing, Supervision. EK: Validation, Writing—review & editing, Supervision. DF: Validation, Writing—review & editing, Supervision. HB: Validation, Writing—review & editing, Supervision. DBI: Writing—review & editing, Supervision. ID: Investigation, Validation, Supervision. ARD: Investigation, Validation, Supervision. IT: Investigation, Validation, Supervision. SP: Validation, Writing—review & editing. KTS: Validation, Writing—review & editing. All authors read and approved the submitted version.
The authors declare that there are no conflicts of interest.
The study was approved by the Ethics Committee of General Hospital 8th September, Skopje, North Macedonia. Ethical approval number: 2796. The study complies with the Declaration of Helsinki.
Informed consent to participate in the study was obtained from all participants.
Not applicable.
The datasets analyzed during this study are available from the corresponding author on reasonable request.
Not applicable.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.